Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100 a aThe identifications for the spots shown in Fig. 1 F1 can be found as supplementary data in Microbiology Online (http://mic.sgmjournals.org).
- 1 September 2002
- journal article
- research article
- Published by Microbiology Society in Microbiology
- Vol. 148 (9) , 2765-2781
- https://doi.org/10.1099/00221287-148-9-2765
Abstract
Proteomics is a powerful tool for analysing differences in gene expression between bacterial strains with alternate phenotypes. Staphylococcus aureus strains are grouped on the basis of their sensitivity to methicillin. Two-dimensional gel electrophoresis was combined with MS to compare the protein profiles of S. aureus strains COL (methicillin-resistant) and 8325 (methicillin-sensitive). Reference mapping via this approach identified 377 proteins that corresponded to 266 distinct ORFs. Amongst these identified proteins were 14 potential virulence factors. The production of 41 ‘hypothetical’ proteins was confirmed, and eight of these appeared to be unique to S. aureus. Strain COL displayed 12 protein spots, which included alkaline-shock protein 23 (Asp23) and cold-shock proteins CspABC, which either were not present in strain 8325 or were present at a significantly lower intensity in this strain. Comparative maps were used to characterize the S. aureus response to treatment with Triton X-100 (TX-100), a detergent that has been shown to reduce methicillin resistance independently of an interaction with the mecA-encoded penicillin-binding protein 2a. In response to growth of the bacteria in the presence of TX-100, 44 protein spots showed altered levels of abundance, and 11 of these spots were found only in COL. The products of genes regulated by σB (the alternative sigma factor), including Asp23 and three proteins of unknown function, and SarA (a regulator of virulence genes) were shown to be present at significantly altered levels. SarA production was induced in TX-100-treated cultures. A protein of the σB operon, RsbV, was only detected in COL and its production was down-regulated in COL when the strain was treated with TX-100, whereas RsbW was present at reduced levels in both strains. Upon growth of both strains in the presence of TX-100, no effects on the production of the essential methicillin-resistance factor FemA were detected, whereas phosphoglucosamine mutase (GlmM) production was reduced in COL alone. This study suggests that proteins of the σB and sarA regulons, as well as other factors, are involved in methicillin resistance in S. aureus.Keywords
This publication has 79 references indexed in Scilit:
- Overexpression of Sigma Factor, ςB, Urges Staphylococcus aureus to Thicken the Cell Wall and to Resist β-LactamsBiochemical and Biophysical Research Communications, 2001
- Human antibody response during sepsis against targets expressed by methicillin resistantStaphylococcus aureusFEMS Immunology & Medical Microbiology, 2000
- Triton X-100-induced lipoteichoic acid release is correlated with the methicillin resistance inStaphylococcus aureusFEMS Microbiology Letters, 2000
- Regulation of σ B-dependent transcription of sigB and asp23 in two different Staphylococcus aureus strainsMolecular Genetics and Genomics, 1999
- Conditions that induce Staphylococcus aureus heat shock proteins also inhibit autolysisFEMS Microbiology Letters, 1998
- Effects of various types of Triton X on the susceptibilities of methicillin-resistant staphylococci to oxacillinFEMS Microbiology Letters, 1997
- Triton X-100 alters the resistance level of methicillin-resistantStaphylococcus aureusto oxacillinFEMS Microbiology Letters, 1995
- The effect of Triton X-100 on the in-vitro susceptibility of methicillin-resistant Staphylococcus aureus to oxacillinJournal of Antimicrobial Chemotherapy, 1994
- Basic local alignment search toolJournal of Molecular Biology, 1990
- Penicillin-binging proteins and the intrinsic resistance to βlactams in Gram-positive cocciJournal of Antimicrobial Chemotherapy, 1985